XBiotech Inc.
XBITXBiotech Inc. is a clinical-stage biopharmaceutical company based in Austin, Texas. It specializes in the research and development of human-derived antibody therapeutics for multiple diseases, including cancer, rheumatological, and infectious diseases.
Drugs in Pipeline
3
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
How XBIT's past catalysts played out
Natrunix
Rheumatoid Arthritis
514G3 (2 mg/kg) plus standard IV antibiotic treatment
Staphylococcus Aureus Bacteremia
Phase I: XB2001 250 mg
Pancreatic Cancer
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Natrunix | Phase 2 | Rheumatoid Arthritis | - | - |
514G3 (2 mg/kg) plus standard IV antibiotic treatment | Phase 2 | Staphylococcus Aureus Bacteremia | - | - |
Phase I: XB2001 250 mg | Phase 2 | Pancreatic Cancer | - | - |
Staphylococcus Aureus Bacteremia
1 drug in this indication
Rheumatoid Arthritis
1 drug in this indication
Pancreatic Cancer
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in XBiotech Inc.'s drug pipeline?→
CatalystAlert tracks 3 drug candidates in XBiotech Inc.'s (XBIT) pipeline across Phase 2. Its lead program is Natrunix (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is XBiotech Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for XBiotech Inc. (XBIT) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track XBIT biotech catalysts?→
Add XBIT to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow XBiotech Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.